News in brief

New oral treatment for hyperkalaemia

Osteoporosis treatment discontinued

Ticagrelor approved for NHS use post-MI

Lenvatinib launched for kidney cancer

MIMS Product Slides

Product overviews prepared by the MIMS team, in a handy slide format.

Click here

Slides are initiated, funded & reviewed by the companies specified.

MIMS app

Access the full drug database and quick-reference tables on the go

Find out more